MEDIPAL HOLDINGS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,312 JPY | +1.29% |
|
+3.05% | +1.16% |
| Sales 2024 | 3,559B 22.61B | Sales 2025 * | 3,607B 22.92B | Capitalization | 486B 3.09B |
|---|---|---|---|---|---|
| Net income 2024 | 41.47B 264M | Net income 2025 * | 34.15B 217M | EV / Sales 2024 | 0.14 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.13 x |
| P/E ratio 2024 |
11.8
x | P/E ratio 2025 * |
14.6
x | Employees | 12,795 |
| Yield 2024 |
2.59% | Yield 2025 * |
2.71% | Free-Float | 84.27% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.29% | ||
| 1 week | +3.05% | ||
| 1 month | -7.09% | ||
| 3 months | +2.28% | ||
| 6 months | -3.22% | ||
| Current year | +1.16% |
1 week
2 204.00
2 317.00
1 month
2 190.502 494.00
Current year
2 170.502 508.50
1 year
2 170.502 683.50
3 years
1 603.002 683.50
5 years
1 603.002 683.50
10 years
1 123.002 689.00
| Managers | Title | Age | Since |
|---|---|---|---|
Shuichi Watanabe
CEO | Chief Executive Officer | 72 | 00-03-31 |
Midori Ito
CMP | Compliance Officer | - | - |
Takeshi Yanagida
CMP | Compliance Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shuichi Watanabe
CEO | Chief Executive Officer | 72 | 00-03-31 |
Toshihide Yoda
ADM | Chief Administrative Officer | 61 | 10-05-31 |
Toshio Asano
BRD | Director/Board Member | 71 | 16-07-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.23% | 42 M€ | +33.07% | ||
| 0.25% | 1,083 M€ | +4.80% | ||
| 0.17% | 17 M€ | +4.55% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 2,312 | +1.29% | 1,180,300 |
| 24-05-30 | 2,282 | +1.90% | 714,600 |
| 24-05-29 | 2,240 | -0.04% | 581,800 |
| 24-05-28 | 2,241 | +0.31% | 352,500 |
| 24-05-27 | 2,234 | -0.42% | 400,400 |
Delayed Quote Japan Exchange, May 31, 2024 at 02:00 am EDT
More quotes
MEDIPAL HOLDINGS CORPORATION engages in the wholesale of pharmaceutical products, cosmetics and daily miscellaneous goods. The Company operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The Company is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.
Sector
Pharmaceuticals
Calendar
2024-07-30
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
2,312
JPY
Average target price
2,505
JPY
Spread / Average Target
+8.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +1.16% | 3.09B | |
| +23.03% | 74.04B | |
| -1.52% | 24.18B | |
| +3.67% | 8.46B | |
| +8.55% | 8.34B | |
| -23.71% | 7.64B | |
| +15.20% | 5.33B | |
| +2.68% | 4.12B | |
| -6.90% | 3.92B | |
| +5.56% | 3.89B |
- Stock Market
- Equities
- 7459 Stock
